Evidence map›Paper›PMID 26764381›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Transcription factor 7-like 1 is involved in hypothalamo-pituitary axis development in mice and humans.

Carles Gaston-Massuet, Mark J McCabe, Valeria Scagliotti, Rodrigo M Young, Gabriela Carreno, Louise C Gregory, Sujatha A Jayakody, Sara Pozzi, Angelica Gualtieri, Basudha Basu and 17 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The imprintedeLife · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 3 countries.

Carles Gaston-MassuetBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Mark J McCabeGenetics and Epigenetics in Health and Disease Section, Genetics and Genomic Medicine Programme, University College London Institute of Child Health, London WC1N 1EH, United Kingdom;
Valeria ScagliottiCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom;
Rodrigo M YoungDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, United Kingdom;
Gabriela CarrenoBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Louise C GregoryGenetics and Epigenetics in Health and Disease Section, Genetics and Genomic Medicine Programme, University College London Institute of Child Health, London WC1N 1EH, United Kingdom;
Sujatha A JayakodyBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Sara PozziBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Angelica GualtieriCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom;
Basudha BasuDevelopmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY 10029;
Markela KoniordouBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Chun-I WuDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois, IL 60607;
Rodrigo E BancalariGenetics and Epigenetics in Health and Disease Section, Genetics and Genomic Medicine Programme, University College London Institute of Child Health, London WC1N 1EH, United Kingdom;
Elisa RahikkalaResearch Unit for Pediatrics, Dermatology, Clinical Genetics, Obstetrics and Gynecology (PEDEGO) and Medical Research Center (MRC) Oulu, University of Oulu, FIN-90029, Oulu, Finland; Department of Clinical Genetics, Oulu University Hospital, FIN-90029, Oulu, Finland;
Riitta VeijolaDepartment of Pediatrics, PEDEGO and MRC Oulu, Oulu University Hospital, University of Oulu, FIN-90014, Oulu, Finland;
Tuija LopponenDepartment of Child Neurology, Kuopio University Hospital, FIN 70029, Kuopio, Finland.
Federica GraziolaCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom;
James TurtonGenetics and Epigenetics in Health and Disease Section, Genetics and Genomic Medicine Programme, University College London Institute of Child Health, London WC1N 1EH, United Kingdom;
Massimo SignoreBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Seyedeh Neda Mousavy GharavyBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Nicoletta CharolidiBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;
Sergei Y SokolDevelopmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY 10029;
Cynthia Lilian AndoniadouBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom;ORCID http://orcid.org/0000-0003-4311-5855
Stephen W WilsonDepartment of Cell and Developmental Biology, University College London, London WC1E 6BT, United Kingdom;ORCID http://orcid.org/0000-0002-8557-5940
Bradley J MerrillDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois, IL 60607;
Mehul T DattaniGenetics and Epigenetics in Health and Disease Section, Genetics and Genomic Medicine Programme, University College London Institute of Child Health, London WC1N 1EH, United Kingdom;
Juan Pedro Martinez-BarberaBirth Defects Research Centre, Developmental Biology and Cancer Programme, University College London Institute of Child Health, London, WC1N 1EH, United Kingdom; j.martinez-barbera@ucl.ac.uk.
University College London · GBQueen Mary University of London · GBIcahn School of Medicine at Mount Sinai · USOulu University Hospital · FIUniversity of Illinois Chicago · USKing's College London · GBKuopio University Hospital · FIWilliam Harvey Research Institute · GB

Funding

Wnt/Beta-catenin and Tcf/Lef factor regulation of pluripotencyR01HD081534 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MERRILL, BRADLEY J · 2014 to 2018
$1.6M
Medical Research Council 099175Medical Research Council 164126Medical Research Council MR/L003775/1Medical Research Council MR/L016729/1Medical Research Council MR/M000125/1NICHD NIH HHS R01 HD081534Wellcome Trust 084361Wellcome Trust 086545Wellcome Trust 104682
6 · The paper itself

Abstract

Aberrant embryonic development of the hypothalamus and/or pituitary gland in humans results in congenital hypopituitarism (CH). Transcription factor 7-like 1 (TCF7L1), an important regulator of the WNT/β-catenin signaling pathway, is expressed in the developing forebrain and pituitary gland, but its role during hypothalamo-pituitary (HP) axis formation or involvement in human CH remains elusive. Using a conditional genetic approach in the mouse, we first demonstrate that TCF7L1 is required in the prospective hypothalamus to maintain normal expression of the hypothalamic signals involved in the induction and subsequent expansion of Rathke's pouch progenitors. Next, we reveal that the function of TCF7L1 during HP axis development depends exclusively on the repressing activity of TCF7L1 and does not require its interaction with β-catenin. Finally, we report the identification of two independent missense variants in human TCF7L1, p.R92P and p.R400Q, in a cohort of patients with forebrain and/or pituitary defects. We demonstrate that these variants exhibit reduced repressing activity in vitro and in vivo relative to wild-type TCF7L1. Together, our data provide support for a conserved molecular function of TCF7L1 as a transcriptional repressor during HP axis development in mammals and identify variants in this transcription factor that are likely to contribute to the etiology of CH.

Indexed as

Hypothalamo-Hypophyseal SystemAnimalsCohort StudiesHumansMicePituitary GlandProsencephalonTranscription Factor 7-Like 1 ProteinTCF7L1 protein, humanTcf7l1 protein, mouseTranscription Factor 7-Like 1 Proteinhypopituitarismpituitaryseptooptic dysplasiaTcf7l1WNT pathway

Identifiers

PMID26764381
PMCPMC4747739
OpenAlexW2235785971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.